Uncertain Gene Therapy Dynamics Will Fuel Challenges Yet Spark Hope
AN
AnalystLowTarget
Not Invested
Consensus Narrative from 10 Analysts
Published
18 May 25
Updated
23 Jul 25
AnalystLowTarget's Fair Value
US$176.00
14.5% undervalued intrinsic discount23 Jul
US$150.49
1Y
-25.3%7D
0.1%